Repurposing doxepin as an antitumor agent: Suppression of cell migration, invasion and survival in non‑small cell lung cancer through ERK/NF‑κB downregulation
Non‑small cell lung cancer (NSCLC) remains a global health challenge due to high metastatic potential and resistance to conventional apoptosis. Doxepin, a tricyclic antidepressant, has shown emerging antitumor potential, yet its efficacy and underlying mechanisms in NSCLC remain poorly understood. The effects of doxepin were evaluated on NSCLC cell lines (A549 and CL1‑5‑F4). Cell viability and apoptosis were assessed using an MTT assay and annexin V/PI flow cytometry. Migratory and invasive capacities were measured using Transwell assays. Western blotting was employed to investigate the ERK/NF‑κB signaling axis and associated regulatory proteins. Doxepin notably suppressed cell viability and induced apoptosis through both extrinsic (caspase‑8) and intrinsic (caspase‑9) pathways in a dose‑ and time‑dependent manner. Furthermore, doxepin treatment markedly inhibited cell migration and invasion. Mechanistically, doxepin inactivated the ERK/NF‑κB axis, leading to the downregulation of anti‑apoptotic (cellular FLICE‑like inhibitory protein, myeloid cell leukemia 1 and X‑linked inhibitor of apoptosis protein) and pro‑metastatic (vascular endothelial growth factor A and matrix metalloproteinase‑9) factors. These findings demonstrate that doxepin effectively inhibits NSCLC progression by promoting apoptosis and suppressing metastasis, suggesting its potential as a repositioned therapeutic agent for lung cancer treatment.
Authors
- Dai-Cheng Dong (ORCID: https://orcid.org/0009-0002-5872-2447)
- Shih-Chieh Chang (ORCID: https://orcid.org/0009-0006-4470-1783)
- Fei-Ting Hsu
- Jiun-I Lai
- Yi-Jen Fang
- Chiung-Yu Chen
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- National Central University (TW)
- National Tsing Hua University (TW)
- National Yang Ming University Hospital (TW)
Publication Details
- Journal
- Oncology Letters
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3892/ol.2026.15960
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Educational Development Foundation